SEC Form 4 · accession 0001225208-26-007620
BOSTON SCIENTIFIC CORP · BSX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Padraig Andrew O'Connor
Officer — EVP, Global Operations
Period of report
Sep 2, 2026
Accepted (ET)
Sep 3, 2026 · 4:34 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000885725
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Sep 2, 2026 | M | 1,171 | $0.00 | A | 8,459 | D | |
| Common Stock | Sep 2, 2026 | F | 567 | $48.37 | D | 7,892 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F3 | — | Sep 2, 2026 | M | 1,171 | D | — | Sep 2, 2029 | Common Stock | 1,171 | 3,516 | D |
Explanation of responses
- F1Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
- F2Includes shares acquired under the Boston Scientific Employee Stock Purchase Plan based upon the most current data available.
- F3Shares of common stock will be issued to the reporting person in four equal annual installments beginning on September 2, 2026, the first anniversary of the date of grant.